SUBSEQUENT EVENTS	12 Months Ended
Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	10. SUBSEQUENT EVENTS Authorized Shares On March 7, 2018, we obtained written consents from stockholders holding a majority of our outstanding voting stock to approve an amendment of the Company’s articles of incorporation, as amended, to increase the number of authorized shares of common stock from 2,000,000,000 to 8,000,000,000. Promissory Notes During January 2018, the Notes with accrued interest of $220,506 were restated. The restated principal balance of $220,506 bears monthly interest at a rate of 2.5% and is due July 12, 2018. In connection with this restated note, we issued 2,000,000 shares of our common stock (See Note 5). During February 2018, the Notes with accrued interest of $65,600 were restated. The restated principal balance of $65,600 bears monthly interest at a rate of 2.5% and is due August 14, 2018. In connection with this restated note, we issued 1,000,000 shares of our common stock (See Note 5). Convertible Notes Payable and Stocks issued with Debt During January to February 2018, we issued promissory notes to unrelated third parties for a total of $109,900 with original issuance discount of $10,900. The note is due in six months from the execution and funding of the notes. In connection with the issuance of these promissory notes, we issued a total 1,000,000 shares of our common stock. The Noteholders have the right to convert the note, until is no longer outstanding into shares of Common Stock at a $0.0008. During February and March 2018, we issued two Convertible Debentures in the amount of $200,000 and $60,000 to an unrelated third party. The notes carries interest at 8% and is due in one year from the execution of the notes, unless previously converted into shares of restricted common stock. The Noteholder has the right to convert the note, until is no longer outstanding into shares of our Common Stock at a price sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date. During February 2018, the notes payable of $150,000 originated in July 2017 with accrued interest of $6,000 was assigned and sold to an unrelated third party in the form of a Convertible Redeemable Note. The note carries interest at 8% and is due on February 19, 2019, unless previously converted into shares of restricted common stock. The Noteholder has the right to convert the note, until is no longer outstanding into shares of Common Stock at sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date. During February 2018, a noteholder converted an outstanding Note issued in June 2017 with an outstanding principal balance of $29,646 for 109,876,500 shares of Common Stock.. During February 2018, a noteholder converted a tranche of an outstanding Note issued in March 2017 with a principal balance of $33,854 for 70,123,500 shares of Common Stock. The noteholder sold and assigned the remaining balance of $46,146 with accrued interest of $3,276 to an unrelated third partyunrelated third party in the form of a Convertible Redeemable Note. The note carries interest at 8% and is due on February 13, 2019, unless previously converted into shares of restricted common stock. The noteholder has the right to convert the note into shares of our Common Stock at sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date. During February 2018, we issued 45,000,000 shares of our restricted stock to Labrys in settlement of a $45,000 note payable issued in October 2017 and the $33,944 outstanding balance of a $34,000 note payable issued in May. During February 2018, the remaining balance of $46,999 for the $110,000 Note originated in December 2016 with accrued interest of $2,820 was assigned and sold to an unrelated third party in the form of a Convertible Redeemable Note. The note carries interest at 8% and is due on February 13, 2019, unless previously converted into shares of restricted common stock. The Noteholder has the right to convert the note into shares of our Common Stock at sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date. In connection with the settlement, we also agreed to issue number of shares of our common stock that equals $125,000 divided by the settlement price prior to May 1, 2018. The settlement price shall be the average closing price for the ten trading days preceding the shares delivery date.

10. SUBSEQUENT EVENTS

Authorized Shares

On March 7, 2018, we obtained written consents from stockholders holding a majority of our outstanding voting stock to approve an amendment of the Company’s articles of incorporation, as amended, to increase the number of authorized shares of common stock from 2,000,000,000 to 8,000,000,000.

Promissory Notes

During January 2018, the Notes with accrued interest of $220,506 were restated. The restated principal balance of $220,506 bears monthly interest at a rate of 2.5% and is due July 12, 2018. In connection with this restated note, we issued 2,000,000 shares of our common stock (See Note 5).

During February 2018, the Notes with accrued interest of $65,600 were restated. The restated principal balance of $65,600 bears monthly interest at a rate of 2.5% and is due August 14, 2018. In connection with this restated note, we issued 1,000,000 shares of our common stock (See Note 5).

Convertible Notes Payable and Stocks issued with Debt

During January to February 2018, we issued promissory notes to unrelated third parties for a total of $109,900 with original issuance discount of $10,900. The note is due in six months from the execution and funding of the notes. In connection with the issuance of these promissory notes, we issued a total 1,000,000 shares of our common stock. The Noteholders have the right to convert the note, until is no longer outstanding into shares of Common Stock at a $0.0008.

During February and March 2018, we issued two Convertible Debentures in the amount of $200,000 and $60,000 to an unrelated third party. The notes carries interest at 8% and is due in one year from the execution of the notes, unless previously converted into shares of restricted common stock. The Noteholder has the right to convert the note, until is no longer outstanding into shares of our Common Stock at a price sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date.

During February 2018, the notes payable of $150,000 originated in July 2017 with accrued interest of $6,000 was assigned and sold to an unrelated third party in the form of a Convertible Redeemable Note. The note carries interest at 8% and is due on February 19, 2019, unless previously converted into shares of restricted common stock. The Noteholder has the right to convert the note, until is no longer outstanding into shares of Common Stock at sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date.

During February 2018, a noteholder converted an outstanding Note issued in June 2017 with an outstanding principal balance of $29,646 for 109,876,500 shares of Common Stock..

During February 2018, a noteholder converted a tranche of an outstanding Note issued in March 2017 with a principal balance of $33,854 for 70,123,500 shares of Common Stock. The noteholder sold and assigned the remaining balance of $46,146 with accrued interest of $3,276 to an unrelated third partyunrelated third party in the form of a Convertible Redeemable Note. The note carries interest at 8% and is due on February 13, 2019, unless previously converted into shares of restricted common stock. The noteholder has the right to convert the note into shares of our Common Stock at sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date.

During February 2018, we issued 45,000,000 shares of our restricted stock to Labrys in settlement of a $45,000 note payable issued in October 2017 and the $33,944 outstanding balance of a $34,000 note payable issued in May.

During February 2018, the remaining balance of $46,999 for the $110,000 Note originated in December 2016 with accrued interest of $2,820 was assigned and sold to an unrelated third party in the form of a Convertible Redeemable Note. The note carries interest at 8% and is due on February 13, 2019, unless previously converted into shares of restricted common stock. The Noteholder has the right to convert the note into shares of our Common Stock at sixty percent of the lowest trading price of our Common Stock for the twenty five prior trading days including the conversion date. In connection with the settlement, we also agreed to issue number of shares of our common stock that equals $125,000 divided by the settlement price prior to May 1, 2018. The settlement price shall be the average closing price for the ten trading days preceding the shares delivery date.